Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer

Antonino Bruno, Barbara Bassani, Davide Giuseppe D'Urso, Ilvana Pitaku, Elisa Cassinotti, Giuseppe Pelosi, Luigi Boni, Lorenzo Dominioni, Douglas M. Noonan, Lorenzo Mortara, Adriana Albini

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

NK cells are effector lymphocytes involved in tumor immunosurveillance; however, in patients with solidmalignancies,NKcells have compromised functions.Wehave previously reported that lung tumor-associated NKcells (TANKs; peripheralblood) andtumor-infiltratingNKcells (TINKs) showproangiogenic,decidualNK-like (dNK) phenotype. In this study, we functionally andmolecularly investigated TINKs and TANKs fromblood and tissue samples of patients with colorectal cancer (CRC), a neoplasmin which inflammation and angiogenesis have clinical relevance, and compared them to NK cells from controls and patients with nononcologic inflammatory bowel disease. CRC TINKs/TANKs showed decreased expression for the activatory marker NKG2D, impaired degranulation activity, a decidual-likeNKpolarization toward the CD56brightCD16dim/-2CD9+CD49+ subset. TINKs and TANKs secreted cytokines with proangiogenic activities, and induce endothelial cell proliferation, migration, adhesion, and the formation of capillary-like structures in vitro. dNK cells release specific proangiogenic factors; amongwhich, angiogenin and invasion-associated enzymes related to theMMP9-TIMP1/2 axis.Here,we describe, for the first time, to our knowledge, the expression of angiogenin,MMP2/9, and TIMP by TANKs in patients with CRC. This phenotype could be relevant to the invasive capabilities and proangiogenic functions of CRC-NK cells and become a novel biomarker. STAT3/STAT5 activation was observed in CRC-TANKs, and treatment with pimozide, a STAT5 inhibitor, reduced endothelial cell capability to form capillary-like networks, inhibiting VEGF and angiogenin production without affecting the levels of TIMP1, TIMP2, and MMP9, indicating that STAT5 is involved in cytokine modulation but not invasion-associated molecules. Combination of Stat5 orMMP inhibitors with immunotherapy could help repolarizeCRCTINKs and TANKs to anti-tumor antimetastatic ones.

Original languageEnglish
Pages (from-to)5365-5377
Number of pages13
JournalFASEB Journal
Volume32
Issue number10
DOIs
Publication statusPublished - Oct 1 2018

Fingerprint

Natural Killer Cells
Tumors
Colorectal Neoplasms
Endothelial cells
Cytokines
Pimozide
Lymphocytes
Cell proliferation
Biomarkers
Endothelial Cells
Vascular Endothelial Growth Factor A
Phenotype
Adhesion
Immunologic Monitoring
Neoplasms
Chemical activation
Modulation
Tissue
Molecules
Inflammatory Bowel Diseases

Keywords

  • Angiogenesis
  • STAT signaling
  • STAT3
  • STAT5
  • VEGF

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer. / Bruno, Antonino; Bassani, Barbara; D'Urso, Davide Giuseppe; Pitaku, Ilvana; Cassinotti, Elisa; Pelosi, Giuseppe; Boni, Luigi; Dominioni, Lorenzo; Noonan, Douglas M.; Mortara, Lorenzo; Albini, Adriana.

In: FASEB Journal, Vol. 32, No. 10, 01.10.2018, p. 5365-5377.

Research output: Contribution to journalArticle

@article{c6f69c2e915c4357a1b631ce3428f22f,
title = "Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer",
abstract = "NK cells are effector lymphocytes involved in tumor immunosurveillance; however, in patients with solidmalignancies,NKcells have compromised functions.Wehave previously reported that lung tumor-associated NKcells (TANKs; peripheralblood) andtumor-infiltratingNKcells (TINKs) showproangiogenic,decidualNK-like (dNK) phenotype. In this study, we functionally andmolecularly investigated TINKs and TANKs fromblood and tissue samples of patients with colorectal cancer (CRC), a neoplasmin which inflammation and angiogenesis have clinical relevance, and compared them to NK cells from controls and patients with nononcologic inflammatory bowel disease. CRC TINKs/TANKs showed decreased expression for the activatory marker NKG2D, impaired degranulation activity, a decidual-likeNKpolarization toward the CD56brightCD16dim/-2CD9+CD49+ subset. TINKs and TANKs secreted cytokines with proangiogenic activities, and induce endothelial cell proliferation, migration, adhesion, and the formation of capillary-like structures in vitro. dNK cells release specific proangiogenic factors; amongwhich, angiogenin and invasion-associated enzymes related to theMMP9-TIMP1/2 axis.Here,we describe, for the first time, to our knowledge, the expression of angiogenin,MMP2/9, and TIMP by TANKs in patients with CRC. This phenotype could be relevant to the invasive capabilities and proangiogenic functions of CRC-NK cells and become a novel biomarker. STAT3/STAT5 activation was observed in CRC-TANKs, and treatment with pimozide, a STAT5 inhibitor, reduced endothelial cell capability to form capillary-like networks, inhibiting VEGF and angiogenin production without affecting the levels of TIMP1, TIMP2, and MMP9, indicating that STAT5 is involved in cytokine modulation but not invasion-associated molecules. Combination of Stat5 orMMP inhibitors with immunotherapy could help repolarizeCRCTINKs and TANKs to anti-tumor antimetastatic ones.",
keywords = "Angiogenesis, STAT signaling, STAT3, STAT5, VEGF",
author = "Antonino Bruno and Barbara Bassani and D'Urso, {Davide Giuseppe} and Ilvana Pitaku and Elisa Cassinotti and Giuseppe Pelosi and Luigi Boni and Lorenzo Dominioni and Noonan, {Douglas M.} and Lorenzo Mortara and Adriana Albini",
year = "2018",
month = "10",
day = "1",
doi = "10.1096/fj.201701103R",
language = "English",
volume = "32",
pages = "5365--5377",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "10",

}

TY - JOUR

T1 - Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer

AU - Bruno, Antonino

AU - Bassani, Barbara

AU - D'Urso, Davide Giuseppe

AU - Pitaku, Ilvana

AU - Cassinotti, Elisa

AU - Pelosi, Giuseppe

AU - Boni, Luigi

AU - Dominioni, Lorenzo

AU - Noonan, Douglas M.

AU - Mortara, Lorenzo

AU - Albini, Adriana

PY - 2018/10/1

Y1 - 2018/10/1

N2 - NK cells are effector lymphocytes involved in tumor immunosurveillance; however, in patients with solidmalignancies,NKcells have compromised functions.Wehave previously reported that lung tumor-associated NKcells (TANKs; peripheralblood) andtumor-infiltratingNKcells (TINKs) showproangiogenic,decidualNK-like (dNK) phenotype. In this study, we functionally andmolecularly investigated TINKs and TANKs fromblood and tissue samples of patients with colorectal cancer (CRC), a neoplasmin which inflammation and angiogenesis have clinical relevance, and compared them to NK cells from controls and patients with nononcologic inflammatory bowel disease. CRC TINKs/TANKs showed decreased expression for the activatory marker NKG2D, impaired degranulation activity, a decidual-likeNKpolarization toward the CD56brightCD16dim/-2CD9+CD49+ subset. TINKs and TANKs secreted cytokines with proangiogenic activities, and induce endothelial cell proliferation, migration, adhesion, and the formation of capillary-like structures in vitro. dNK cells release specific proangiogenic factors; amongwhich, angiogenin and invasion-associated enzymes related to theMMP9-TIMP1/2 axis.Here,we describe, for the first time, to our knowledge, the expression of angiogenin,MMP2/9, and TIMP by TANKs in patients with CRC. This phenotype could be relevant to the invasive capabilities and proangiogenic functions of CRC-NK cells and become a novel biomarker. STAT3/STAT5 activation was observed in CRC-TANKs, and treatment with pimozide, a STAT5 inhibitor, reduced endothelial cell capability to form capillary-like networks, inhibiting VEGF and angiogenin production without affecting the levels of TIMP1, TIMP2, and MMP9, indicating that STAT5 is involved in cytokine modulation but not invasion-associated molecules. Combination of Stat5 orMMP inhibitors with immunotherapy could help repolarizeCRCTINKs and TANKs to anti-tumor antimetastatic ones.

AB - NK cells are effector lymphocytes involved in tumor immunosurveillance; however, in patients with solidmalignancies,NKcells have compromised functions.Wehave previously reported that lung tumor-associated NKcells (TANKs; peripheralblood) andtumor-infiltratingNKcells (TINKs) showproangiogenic,decidualNK-like (dNK) phenotype. In this study, we functionally andmolecularly investigated TINKs and TANKs fromblood and tissue samples of patients with colorectal cancer (CRC), a neoplasmin which inflammation and angiogenesis have clinical relevance, and compared them to NK cells from controls and patients with nononcologic inflammatory bowel disease. CRC TINKs/TANKs showed decreased expression for the activatory marker NKG2D, impaired degranulation activity, a decidual-likeNKpolarization toward the CD56brightCD16dim/-2CD9+CD49+ subset. TINKs and TANKs secreted cytokines with proangiogenic activities, and induce endothelial cell proliferation, migration, adhesion, and the formation of capillary-like structures in vitro. dNK cells release specific proangiogenic factors; amongwhich, angiogenin and invasion-associated enzymes related to theMMP9-TIMP1/2 axis.Here,we describe, for the first time, to our knowledge, the expression of angiogenin,MMP2/9, and TIMP by TANKs in patients with CRC. This phenotype could be relevant to the invasive capabilities and proangiogenic functions of CRC-NK cells and become a novel biomarker. STAT3/STAT5 activation was observed in CRC-TANKs, and treatment with pimozide, a STAT5 inhibitor, reduced endothelial cell capability to form capillary-like networks, inhibiting VEGF and angiogenin production without affecting the levels of TIMP1, TIMP2, and MMP9, indicating that STAT5 is involved in cytokine modulation but not invasion-associated molecules. Combination of Stat5 orMMP inhibitors with immunotherapy could help repolarizeCRCTINKs and TANKs to anti-tumor antimetastatic ones.

KW - Angiogenesis

KW - STAT signaling

KW - STAT3

KW - STAT5

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=85052154451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052154451&partnerID=8YFLogxK

U2 - 10.1096/fj.201701103R

DO - 10.1096/fj.201701103R

M3 - Article

AN - SCOPUS:85052154451

VL - 32

SP - 5365

EP - 5377

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 10

ER -